Literature DB >> 30106766

Inflammatory and Comorbid Features of Children Admitted to a PICU for Status Asthmaticus.

Jocelyn R Grunwell1,2, Curtis Travers1, Anne M Fitzpatrick1,2.   

Abstract

OBJECTIVES: To determine risk factors associated with admission to a PICU with or without endotracheal intubation for an asthma exacerbation. We hypothesized that children with critical and near-fatal asthma would have distinguishing clinical features but varying degrees of asthma severity and measures of type 2 inflammation.
DESIGN: Retrospective analysis of prospectively collected data of children with asthma recruited into outpatient asthma clinical research studies at Emory University between 2004 and 2015.
SETTING: Large, free-standing academic quaternary care children's hospital in Atlanta, GA. PATIENTS: Children 6-18 years old with physician-diagnosed and confirmed asthma.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: A total of 579 children were analyzed with 170 children (29.4%) being admitted to the PICU for an asthma exacerbation in their lifetime. Of these 170 children with a history of critical asthma, 24.1% were classified as having mild-to-moderate asthma, and 83 of 170 children (48.8%) had been intubated and experienced near-fatal asthma. Multiple logistic regression was used to identify risk factors associated with increased odds of PICU admission with or without endotracheal intubation. Hospitalization within the prior 12 months of survey (odds ratio, 8.19; 95% CI, 4.83-13.89), a history of pneumonia (odds ratio, 2.56; 95% CI, 1.52-4.29), having a designation of increased chronic asthma severity on high-dose inhaled corticosteroids (odds ratio, 2.76; 95% CI, 1.62-4.70), having a father with asthma (odds ratio, 2.15; 95% CI, 1.23-3.76), living in a region with a higher burden of poverty (odds ratio, 1.28; 95% CI, 1.02-1.61), and being of black race (odds ratio, 2.01; 95% CI, 1.05-3.84) were all associated with increased odds of PICU admission with or without intubation.
CONCLUSIONS: Our findings suggest that there are factors associated with critical and near-fatal asthma, distinct from the chronic asthma severity designations, that should be the focus of future investigation.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30106766      PMCID: PMC6218278          DOI: 10.1097/PCC.0000000000001695

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  33 in total

1.  Trends in admissions for pediatric status asthmaticus in New Jersey over a 15-year period.

Authors:  Mary E Hartman; Walter T Linde-Zwirble; Derek C Angus; R Scott Watson
Journal:  Pediatrics       Date:  2010-09-27       Impact factor: 7.124

2.  Time to Asthma-Related Readmission in Children Admitted to the ICU for Asthma.

Authors:  Sze Man Tse; Christian Samson
Journal:  Pediatr Crit Care Med       Date:  2017-12       Impact factor: 3.624

3.  The molecular phenotype of severe asthma in children.

Authors:  Anne M Fitzpatrick; Melinda Higgins; Fernando Holguin; Lou Ann S Brown; W Gerald Teague
Journal:  J Allergy Clin Immunol       Date:  2010-04       Impact factor: 10.793

Review 4.  Early-life respiratory infections and asthma development: role in disease pathogenesis and potential targets for disease prevention.

Authors:  Avraham Beigelman; Leonard B Bacharier
Journal:  Curr Opin Allergy Clin Immunol       Date:  2016-04

Review 5.  Type 2 inflammation in asthma--present in most, absent in many.

Authors:  John V Fahy
Journal:  Nat Rev Immunol       Date:  2015-01       Impact factor: 53.106

6.  Baseline Features of the Severe Asthma Research Program (SARP III) Cohort: Differences with Age.

Authors:  W Gerald Teague; Brenda R Phillips; John V Fahy; Sally E Wenzel; Anne M Fitzpatrick; Wendy C Moore; Annette T Hastie; Eugene R Bleecker; Deborah A Meyers; Stephen P Peters; Mario Castro; Andrea M Coverstone; Leonard B Bacharier; Ngoc P Ly; Michael C Peters; Loren C Denlinger; Sima Ramratnam; Ronald L Sorkness; Benjamin M Gaston; Serpil C Erzurum; Suzy A A Comhair; Ross E Myers; Joe Zein; Mark D DeBoer; Anne-Marie Irani; Elliot Israel; Bruce Levy; Juan Carlos Cardet; Wanda Phipatanakul; Jonathan M Gaffin; Fernando Holguin; Merritt L Fajt; Shean J Aujla; David T Mauger; Nizar N Jarjour
Journal:  J Allergy Clin Immunol Pract       Date:  2017-08-31

Review 7.  Severe Asthma in Children: Lessons Learned and Future Directions.

Authors:  Anne M Fitzpatrick
Journal:  J Allergy Clin Immunol Pract       Date:  2016 Jan-Feb

8.  Severe exacerbations in children with mild asthma: characterizing a pediatric phenotype.

Authors:  Christopher L Carroll; Craig M Schramm; Aaron R Zucker
Journal:  J Asthma       Date:  2008-08       Impact factor: 2.515

9.  International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.

Authors:  Kian Fan Chung; Sally E Wenzel; Jan L Brozek; Andrew Bush; Mario Castro; Peter J Sterk; Ian M Adcock; Eric D Bateman; Elisabeth H Bel; Eugene R Bleecker; Louis-Philippe Boulet; Christopher Brightling; Pascal Chanez; Sven-Erik Dahlen; Ratko Djukanovic; Urs Frey; Mina Gaga; Peter Gibson; Qutayba Hamid; Nizar N Jajour; Thais Mauad; Ronald L Sorkness; W Gerald Teague
Journal:  Eur Respir J       Date:  2013-12-12       Impact factor: 16.671

10.  Increased risk of wheeze and decreased lung function after respiratory syncytial virus infection.

Authors:  Kim Zomer-Kooijker; Cornelis K van der Ent; Marieke J J Ermers; Cuno S P M Uiterwaal; Maroeska M Rovers; Louis J Bont
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

View more
  5 in total

1.  Geospatial Analysis of Social Determinants of Health Identifies Neighborhood Hot Spots Associated With Pediatric Intensive Care Use for Life-Threatening Asthma.

Authors:  Jocelyn R Grunwell; Cydney Opolka; Carrie Mason; Anne M Fitzpatrick
Journal:  J Allergy Clin Immunol Pract       Date:  2021-11-11

2.  Risk factors for intensive care admission in children with severe acute asthma in the Netherlands: a prospective multicentre study.

Authors:  Shelley A Boeschoten; Annemie L Boehmer; Peter J Merkus; Joost van Rosmalen; Johan C de Jongste; Pieter L A Fraaij; Richard Molenkamp; Sabien G Heisterkamp; Job B van Woensel; Berber Kapitein; Eric G Haarman; Roelie M Wösten-van Asperen; Martin C Kneyber; Joris Lemson; Stan Hartman; Dick A van Waardenburg; Heleen E Bunker-Wiersma; Carole N Brouwer; Bart E van Ewijk; Anneke M Landstra; Mariel Verwaal; Anja A Vaessen-Verberne; Sanne Hammer; Corinne M Buysse; Matthijs de Hoog
Journal:  ERJ Open Res       Date:  2020-08-17

3.  Factors Associated with Failure of Intermittent Nebulization with Short-Acting Beta-Agonists in Children with Severe Asthma Exacerbation.

Authors:  Prapasri Kulalert; Phichayut Phinyo; Jayanton Patumanond; Chutima Smathakanee; Wantida Chuenjit; Sira Nanthapisal
Journal:  J Asthma Allergy       Date:  2020-08-25

4.  Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 at a Tertiary Care Medical Center in New York City.

Authors:  Jerry Y Chao; Kim R Derespina; Betsy C Herold; David L Goldman; Margaret Aldrich; Jacqueline Weingarten; Henry M Ushay; Michael D Cabana; Shivanand S Medar
Journal:  J Pediatr       Date:  2020-05-11       Impact factor: 4.406

5.  Continuous versus intermittent short-acting β2-agonists nebulization as first-line therapy in hospitalized children with severe asthma exacerbation: a propensity score matching analysis.

Authors:  Prapasri Kulalert; Phichayut Phinyo; Jayanton Patumanond; Chutima Smathakanee; Wantida Chuenjit; Sira Nanthapisal
Journal:  Asthma Res Pract       Date:  2020-07-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.